The litigation alleges that Insulet Corporation issued false or misleading statements regarding the integrity of its manufacturing controls and internal procedures. The complaint asserts that these undisclosed deficiencies created a heightened risk of regulatory violations and potential product safety hazards. When these details surfaced, the company’s share price was impacted, leading to financial losses for stockholders who acquired their positions during the class period.

Investors wishing to participate in the proceedings or act as a representative party must move the court by the end of August. While the Rosen Law Firm is soliciting clients for the litigation, the court has not yet certified a class. Shareholders retain the right to select their own counsel, remain absent class members, or move to lead the litigation without the requirement of out-of-pocket expenses, as the firm operates on a contingency fee basis.